CymaBay Therapeutics Inc. (CBAY) Receives Average Rating of "Buy" from Brokerages

... Fund Management LLC bought a new position in shares of CymaBay Therapeutics in the 3rd quarter worth $404,000. Ardsley Advisory Partners lifted its holdings in shares of CymaBay Therapeutics by 66.2% in the 2nd quarter. Ardsley Advisory Partners now ...
http://ift.tt/2hIGB67